The Vinod Balachandran Lab

Our laboratory investigates the fundamental relationships between antigens and T cells in solid tumors. We are interested in understanding how the spectrum of cancer antigens modulate T cell phenotype, function, fate, and plasticity in human cancer. Our group has specifically focused on human pancreatic cancer, and has used immunologic, genomic, molecular, and computational techniques to identify T cell antigens in rare pancreatic cancer survivors, as a platform for novel biomarker and target discovery, and to uncover principles governing antigen-T cell interactions. Our primary objective is to deepen our understanding of T cell immunobiology in cancer, and to facilitate development of novel cancer vaccines and immunotherapies.

Pictured: Dr. Vinod Balachandran

Vinod Balachandran, MD

Member, David. M Rubenstein Center for Pancreatic Cancer Research

Research Focus

Surgeon scientist Vinod Balachandran investigates T cell immunobiology in pancreatic cancer.

Education

MD, State University of New York at Stony Brook
Publications
Learn more
Selected Achievements
  • Society of Immunotherapy for Cancer Presidential Award (2017)
  • National Cancer Institute Cancer Moonshot Award (2017)
  • Damon Runyon Clinical Investigator Award (2017)
  • AACR/Pancreatic Cancer Action Network Career Development Award (2017)
  • NCI Paul Calabresi Career Development Award (2016)
Read more
  • Society of Surgical Oncology Harvey Barker Award (2015)
  • David and Monica Gorin Fellow Award (2013)
  • Memorial Sloan Kettering Chairman’s Award for Best Basic Science Research (2010)
  • Society of University Surgeons Research Fellowship Award (2009)
  • Alpha Omega Alpha